# ArchiMed completes $1.2B acquisition of Natus Medical

ArchiMed's MED Platform II fund completed its acquisition of Natus Medical, a developer of medical devices for neurological disorders, for a total equity value of $1.2 billion. Natus shareholders received $33.50 per share.

- Type: Acquisition
- Announced: 2022-07-21
- Where: Middleton, Wisconsin, United States
- Value: $1.20B
- Status: completed
- Products: medical devices for screening, diagnosing and treating neurological disorders
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [ARCHIMED](https://endata.com/companies/34181.md) (acquirer)
- [Natus Medical](https://endata.com/companies/44289.md) (target)

## Sources

- [massdevice.com](https://www.massdevice.com/archimed-acquisition-natus-medical/), 2022-07-21: "ArchiMed’s mix of operational, medical, scientific and financial expertise will help us continue our mission to serve our customers as we internationalize and grow our business."
- [medicaldevice-network.com](https://www.medicaldevice-network.com/news/archimed-natus-medical-deal-complete/), 2022-07-22: "Together with management, we'll significantly expand the reach and breadth of Natus' market leading products, reinforce and focus research and development, and pursue acquisitions of complementary businesses."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.